Dosimetric evaluation of MRI-based treatment planning for prostate cancer

Lili Chen, R. A. Price, T. B. Nguyen, L. Wang, J. S. Li, L. Qin, M. Ding, E. Palacio, C. M. Ma, Alan Pollack

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The purpose of this study is to evaluate the dosimetric accuracy of MRI-based treatment planning for prostate cancer using a commercial radiotherapy treatment planning system. Three-dimensional conformal plans for 15 prostate patients were generated using the AcQPlan system. For each patient, dose distributions were calculated using patient CT data with and without heterogeneity correction, and using patient MRI data without heterogeneity correction. MR images were post-processed using the gradient distortion correction (GDC) software. The distortion corrected MR images were fused to the corresponding CT for each patient for target and structure delineation. The femoral heads were delineated based on CT. Other anatomic structures relevant to the treatment (i.e., prostate, seminal vesicles, lymph notes, rectum and bladder) were delineated based on MRI. The external contours were drawn separately on CT and MRI. The same internal contours were used in the dose calculation using CT- and MRI-based geometries by directly transferring them between MRI and CT as needed. Treatment plans were evaluated based on maximum dose, isodose distributions and dose-volume histograms. The results confirm previous investigations that there is no clinically significant dose difference between CT-based prostate plans with and without heterogeneity correction. The difference in the target dose between CT- and MRI-based plans using homogeneous geometry was within 2.5%. Our results suggest that MRI-based treatment planning is suitable for radiotherapy of prostate cancer.

Original languageEnglish
Pages (from-to)5157-5170
Number of pages14
JournalPhysics in Medicine and Biology
Volume49
Issue number22
DOIs
StatePublished - Nov 21 2004
Externally publishedYes

Fingerprint

Magnetic resonance imaging
planning
Prostatic Neoplasms
cancer
Planning
dosage
evaluation
Prostate
Radiotherapy
radiation therapy
Therapeutics
lymph
Seminal Vesicles
Lymph
rectum
Thigh
Rectum
delineation
bladder
geometry

ASJC Scopus subject areas

  • Biomedical Engineering
  • Physics and Astronomy (miscellaneous)
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Dosimetric evaluation of MRI-based treatment planning for prostate cancer. / Chen, Lili; Price, R. A.; Nguyen, T. B.; Wang, L.; Li, J. S.; Qin, L.; Ding, M.; Palacio, E.; Ma, C. M.; Pollack, Alan.

In: Physics in Medicine and Biology, Vol. 49, No. 22, 21.11.2004, p. 5157-5170.

Research output: Contribution to journalArticle

Chen, L, Price, RA, Nguyen, TB, Wang, L, Li, JS, Qin, L, Ding, M, Palacio, E, Ma, CM & Pollack, A 2004, 'Dosimetric evaluation of MRI-based treatment planning for prostate cancer', Physics in Medicine and Biology, vol. 49, no. 22, pp. 5157-5170. https://doi.org/10.1088/0031-9155/49/22/010
Chen, Lili ; Price, R. A. ; Nguyen, T. B. ; Wang, L. ; Li, J. S. ; Qin, L. ; Ding, M. ; Palacio, E. ; Ma, C. M. ; Pollack, Alan. / Dosimetric evaluation of MRI-based treatment planning for prostate cancer. In: Physics in Medicine and Biology. 2004 ; Vol. 49, No. 22. pp. 5157-5170.
@article{7e64423086864a9a9c9b09d5212dc5f3,
title = "Dosimetric evaluation of MRI-based treatment planning for prostate cancer",
abstract = "The purpose of this study is to evaluate the dosimetric accuracy of MRI-based treatment planning for prostate cancer using a commercial radiotherapy treatment planning system. Three-dimensional conformal plans for 15 prostate patients were generated using the AcQPlan system. For each patient, dose distributions were calculated using patient CT data with and without heterogeneity correction, and using patient MRI data without heterogeneity correction. MR images were post-processed using the gradient distortion correction (GDC) software. The distortion corrected MR images were fused to the corresponding CT for each patient for target and structure delineation. The femoral heads were delineated based on CT. Other anatomic structures relevant to the treatment (i.e., prostate, seminal vesicles, lymph notes, rectum and bladder) were delineated based on MRI. The external contours were drawn separately on CT and MRI. The same internal contours were used in the dose calculation using CT- and MRI-based geometries by directly transferring them between MRI and CT as needed. Treatment plans were evaluated based on maximum dose, isodose distributions and dose-volume histograms. The results confirm previous investigations that there is no clinically significant dose difference between CT-based prostate plans with and without heterogeneity correction. The difference in the target dose between CT- and MRI-based plans using homogeneous geometry was within 2.5{\%}. Our results suggest that MRI-based treatment planning is suitable for radiotherapy of prostate cancer.",
author = "Lili Chen and Price, {R. A.} and Nguyen, {T. B.} and L. Wang and Li, {J. S.} and L. Qin and M. Ding and E. Palacio and Ma, {C. M.} and Alan Pollack",
year = "2004",
month = "11",
day = "21",
doi = "10.1088/0031-9155/49/22/010",
language = "English",
volume = "49",
pages = "5157--5170",
journal = "Physics in Medicine and Biology",
issn = "0031-9155",
publisher = "IOP Publishing Ltd.",
number = "22",

}

TY - JOUR

T1 - Dosimetric evaluation of MRI-based treatment planning for prostate cancer

AU - Chen, Lili

AU - Price, R. A.

AU - Nguyen, T. B.

AU - Wang, L.

AU - Li, J. S.

AU - Qin, L.

AU - Ding, M.

AU - Palacio, E.

AU - Ma, C. M.

AU - Pollack, Alan

PY - 2004/11/21

Y1 - 2004/11/21

N2 - The purpose of this study is to evaluate the dosimetric accuracy of MRI-based treatment planning for prostate cancer using a commercial radiotherapy treatment planning system. Three-dimensional conformal plans for 15 prostate patients were generated using the AcQPlan system. For each patient, dose distributions were calculated using patient CT data with and without heterogeneity correction, and using patient MRI data without heterogeneity correction. MR images were post-processed using the gradient distortion correction (GDC) software. The distortion corrected MR images were fused to the corresponding CT for each patient for target and structure delineation. The femoral heads were delineated based on CT. Other anatomic structures relevant to the treatment (i.e., prostate, seminal vesicles, lymph notes, rectum and bladder) were delineated based on MRI. The external contours were drawn separately on CT and MRI. The same internal contours were used in the dose calculation using CT- and MRI-based geometries by directly transferring them between MRI and CT as needed. Treatment plans were evaluated based on maximum dose, isodose distributions and dose-volume histograms. The results confirm previous investigations that there is no clinically significant dose difference between CT-based prostate plans with and without heterogeneity correction. The difference in the target dose between CT- and MRI-based plans using homogeneous geometry was within 2.5%. Our results suggest that MRI-based treatment planning is suitable for radiotherapy of prostate cancer.

AB - The purpose of this study is to evaluate the dosimetric accuracy of MRI-based treatment planning for prostate cancer using a commercial radiotherapy treatment planning system. Three-dimensional conformal plans for 15 prostate patients were generated using the AcQPlan system. For each patient, dose distributions were calculated using patient CT data with and without heterogeneity correction, and using patient MRI data without heterogeneity correction. MR images were post-processed using the gradient distortion correction (GDC) software. The distortion corrected MR images were fused to the corresponding CT for each patient for target and structure delineation. The femoral heads were delineated based on CT. Other anatomic structures relevant to the treatment (i.e., prostate, seminal vesicles, lymph notes, rectum and bladder) were delineated based on MRI. The external contours were drawn separately on CT and MRI. The same internal contours were used in the dose calculation using CT- and MRI-based geometries by directly transferring them between MRI and CT as needed. Treatment plans were evaluated based on maximum dose, isodose distributions and dose-volume histograms. The results confirm previous investigations that there is no clinically significant dose difference between CT-based prostate plans with and without heterogeneity correction. The difference in the target dose between CT- and MRI-based plans using homogeneous geometry was within 2.5%. Our results suggest that MRI-based treatment planning is suitable for radiotherapy of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=9744252979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9744252979&partnerID=8YFLogxK

U2 - 10.1088/0031-9155/49/22/010

DO - 10.1088/0031-9155/49/22/010

M3 - Article

C2 - 15609565

AN - SCOPUS:9744252979

VL - 49

SP - 5157

EP - 5170

JO - Physics in Medicine and Biology

JF - Physics in Medicine and Biology

SN - 0031-9155

IS - 22

ER -